Is AngioDynamics, Inc. (ANGO) a Buy, Sell, or Hold?
NASDAQ : ANGO
AngioDynamics, Inc. — Insider Trades
$15.965 USD
$0.21 (1.37%)
- Volume
- 112.99K
- Average Volume
- 439.52K
- Market Capitalization
- $659.87M
- P/E Ratio
- -18.14
- Dividend Yield
- 0.00%
- Price Target
- $19.50
- Year High
- $16.05
- Year Low
- $8.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.19
Insider Activity Summary (Last 12 Months)
Insiders Buying
44
Insiders Selling
46
Amount of Insider Selling
$487.76K
ANGO Insider Buying/Selling by Quarter
ANGO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-30 | S-Sale | 14.72 | 2026-07-31 |
| Piccinini Laura | officer: SVP International | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Piccinini Laura | officer: SVP International | 2026-07-22 | F-InKind | 13.82 | 2026-07-24 |
| Piccinini Laura | officer: SVP International | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-22 | F-InKind | 13.82 | 2026-07-24 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-22 | F-InKind | 13.82 | 2026-07-24 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Clemmer James C | director, officer: President and CEO | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Clemmer James C | director, officer: President and CEO | 2026-07-22 | F-InKind | 13.82 | 2026-07-24 |
| Clemmer James C | director, officer: President and CEO | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-22 | F-InKind | 13.82 | 2026-07-24 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-22 | M-Exempt | 0 | 2026-07-24 |
| REED JAN STERN | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Licitra Karen A | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| JOHNSON WESLEY | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| DONNELLY HOWARD W | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Burgess Lorinda | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Auen Eileen O'Shea | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Tarnoff Michael E | director | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Piccinini Laura | officer: SVP International | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Piccinini Laura | officer: SVP International | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2026-07-15 | A-Award | 0 | 2026-07-22 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2026-07-16 | F-InKind | 14.14 | 2026-07-21 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-16 | F-InKind | 14.14 | 2026-07-21 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-17 | F-InKind | 13.51 | 2026-07-21 |
| Trowbridge Stephen A | officer: EVP and CFO | 2026-07-20 | F-InKind | 13.71 | 2026-07-21 |
| Piccinini Laura | officer: SVP International | 2026-07-16 | F-InKind | 14.14 | 2026-07-21 |
| Piccinini Laura | officer: SVP International | 2026-07-17 | F-InKind | 13.51 | 2026-07-21 |
| Piccinini Laura | officer: SVP International | 2026-07-20 | F-InKind | 13.71 | 2026-07-21 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-16 | F-InKind | 14.14 | 2026-07-21 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-17 | F-InKind | 13.51 | 2026-07-21 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2026-07-20 | F-InKind | 13.71 | 2026-07-21 |
| Clemmer James C | director, officer: President and CEO | 2026-07-16 | F-InKind | 14.14 | 2026-07-21 |
| Clemmer James C | director, officer: President and CEO | 2026-07-17 | F-InKind | 13.51 | 2026-07-21 |
| Clemmer James C | director, officer: President and CEO | 2026-07-19 | F-InKind | 13.51 | 2026-07-21 |
| Clemmer James C | director, officer: President and CEO | 2026-07-19 | F-InKind | 13.51 | 2026-07-21 |
| Clemmer James C | director, officer: President and CEO | 2026-07-20 | F-InKind | 13.71 | 2026-07-21 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-16 | F-InKind | 14.14 | 2026-07-21 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-17 | F-InKind | 13.51 | 2026-07-21 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2026-07-20 | F-InKind | 13.71 | 2026-07-21 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2025-10-21 | P-Purchase | 11.81 | 2025-10-22 |
| Trowbridge Stephen A | officer: EVP and CFO | 2025-10-13 | P-Purchase | 11.16 | 2025-10-14 |
| Clemmer James C | director, officer: President and CEO | 2025-10-09 | P-Purchase | 11.15 | 2025-10-09 |
| Trowbridge Stephen A | officer: EVP and CFO | 2025-07-19 | F-InKind | 8.69 | 2025-07-22 |
| Trowbridge Stephen A | officer: EVP and CFO | 2025-07-20 | F-InKind | 8.69 | 2025-07-22 |
| Trowbridge Stephen A | officer: EVP and CFO | 2025-07-21 | F-InKind | 8.99 | 2025-07-22 |
| Piccinini Laura | officer: SVP International | 2025-07-19 | F-InKind | 8.69 | 2025-07-22 |
| Piccinini Laura | officer: SVP International | 2025-07-20 | F-InKind | 8.69 | 2025-07-22 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2025-07-19 | F-InKind | 8.69 | 2025-07-22 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2025-07-20 | F-InKind | 8.69 | 2025-07-22 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2025-07-21 | F-InKind | 8.99 | 2025-07-22 |
| Clemmer James C | director, officer: President and CEO | 2025-07-19 | F-InKind | 8.69 | 2025-07-22 |
| Clemmer James C | director, officer: President and CEO | 2025-07-19 | F-InKind | 8.69 | 2025-07-22 |
| Clemmer James C | director, officer: President and CEO | 2025-07-20 | F-InKind | 8.69 | 2025-07-22 |
| Clemmer James C | director, officer: President and CEO | 2025-07-20 | F-InKind | 8.99 | 2025-07-22 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2025-07-19 | F-InKind | 8.69 | 2025-07-22 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2025-07-20 | F-InKind | 8.69 | 2025-07-22 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2025-07-21 | F-InKind | 8.99 | 2025-07-22 |
| Piccinini Laura | officer: SVP International | 2025-07-17 | F-InKind | 8.74 | 2025-07-21 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Clemmer James C | director, officer: President and CEO | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Clemmer James C | director, officer: President and CEO | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Trowbridge Stephen A | officer: EVP and CFO | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Trowbridge Stephen A | officer: EVP and CFO | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Campbell Chad Thomas | officer: SVP/GM, Vascular Access | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| DONNELLY HOWARD W | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Piccinini Laura | officer: SVP International | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Burgess Lorinda | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Piccinini Laura | officer: SVP International | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Auen Eileen O'Shea | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Tarnoff Michael E | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| REED JAN STERN | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Licitra Karen A | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| JOHNSON WESLEY | director | 2025-07-16 | A-Award | 0 | 2025-07-18 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2025-01-16 | S-Sale | 12.31 | 2025-01-17 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2024-12-02 | A-Award | 7.14 | 2024-12-04 |
| Weiss Lawrence T | officer: SVP, Chief Legal Officer | 2024-12-02 | A-Award | 0 | 2024-12-04 |
| Weiss Lawrence T | 2024-12-02 | 0 | 2024-12-04 | ||
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2024-10-10 | P-Purchase | 6.08 | 2024-10-10 |
| Nighan Warren JR | officer: SVP Quality and Regulatory | 2024-10-07 | P-Purchase | 6.09 | 2024-10-10 |
| Trowbridge Stephen A | officer: EVP and CFO | 2024-10-08 | P-Purchase | 5.86 | 2024-10-08 |
| Clemmer James C | director, officer: President and CEO | 2024-10-07 | P-Purchase | 6.03 | 2024-10-08 |
| Piccinini Laura | officer: SVP International | 2024-07-17 | M-Exempt | 0 | 2024-08-02 |
| Piccinini Laura | officer: SVP International | 2024-07-17 | F-InKind | 7.4 | 2024-08-02 |
| Piccinini Laura | officer: SVP International | 2024-07-17 | M-Exempt | 0 | 2024-08-02 |